Open AccessExceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High Tumor Mutation Burden: Case Report and Literature Review
Author(s) -
Joanne Lundy,
Owen McKay,
Daniel Croagh,
Vinod Ganju
Publication year - 2022
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.21.00437
Subject(s) - pembrolizumab , olaparib , germline mutation , mutation , germline , cancer research , medicine , oncology , genetics , biology , polymerase , cancer , immunotherapy , poly adp ribose polymerase , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom